Alder Biopharmaceuticals Inc. (ALDR) was a big mover last session, as the company saw its shares rise over 5% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 25.6% in the past one-month time frame.
In the last 30 days, the company witnessed 1downward estimate revision and the Zacks Consensus Estimate of a loss widened over the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.
Alder Biopharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other attractive players in the med-biomed industry include Heska Corporation (HSKA), Illumina Inc. (ILMN) and Cambrex Corporation. (CBM), all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ALDER BIOPHARMACEUTICALS INC (ALDR): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
ILLUMINA INC (ILMN): Free Stock Analysis Report
CAMBREX CORP (CBM): Free Stock Analysis Report
Zacks Investment Research
Alder Biopharmaceuticals (ALDR) in Focus: Stock Up 5.2%
Terms and Privacy Policy